Jitendra – Page 7 – Scilex Holding

02 Feb

SEC FIlings

Current report

February 2, 2023
Posted by Jitendra

29 Jan

Press Release

Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued an “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock

January 29, 2023
Posted by Jitendra

Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued an “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock PALO ALTO, January 29, 2023 (GLOBE NEWSWIRE)...

03 Jan

SEC FIlings

Current Report

January 3, 2023
Posted by Jitendra

09 Dec

SEC FIlings

Notice of Effectiveness

December 14, 2022
Posted by Jitendra

09 Dec

SEC FIlings

Prospectus [Rule 424(b)(3)]

December 12, 2022
Posted by Jitendra

09 Dec

SEC FIlings

Statement of acquisition of beneficial ownership by individuals – amendment

December 14, 2022
Posted by Jitendra

02 Dec

SEC FIlings

Statement of changes in beneficial ownership of securities

December 14, 2022
Posted by Jitendra

30 Nov

SEC FIlings

IPO Investment Prospectus

November 30, 2022
Posted by Jitendra

25 Nov

SEC FIlings

Statement of changes in beneficial ownership of securities

December 14, 2022
Posted by Jitendra

23 Nov

SEC FIlings

Statement of changes in beneficial ownership of securities

December 14, 2022
Posted by Jitendra

Posts by Jitendra

Current report

Scilex Holding Company Announces that its Majority Stockholder, Sorrento Therapeutics, Inc., has Issued an “FAQ” Regarding the Dividend of Scilex Holding Company Common Stock

Current Report

Notice of Effectiveness

Prospectus [Rule 424(b)(3)]

Statement of acquisition of beneficial ownership by individuals – amendment

Statement of changes in beneficial ownership of securities

IPO Investment Prospectus

Statement of changes in beneficial ownership of securities

Statement of changes in beneficial ownership of securities

Gloperba Launch – Nasdaq-2024

A randomized, placebo-controlled trial of long-acting dexamethasone viscous gel delivered by transforaminal injection for lumbosacral radicular pain

Gout Awareness Day – May 22

Decreased Opioid Utilization with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch: A Retrospective Claims Analysis

Retrospective Claims Analysis of Decreased Healthcare Visits with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch